Medical aid-in-dying laws are on the rise in the U.S., but patients still face substantial barriers to access, according to an analysis by Mara Buchbinder, PhD.
Eight U.S. jurisdictions (seven states plus the District of Columbia) now allow physicians to prescribe a lethal dose of medication to a mentally competent, terminally ill patient, provided that certain conditions are met.
Hawaii passed a medical aid-in-dying law in April, and similar proposed laws are currently under consideration in North Carolina, New York and other states.
However, in the states were medical aid-in-dying laws are already in effect, patients who wish to use them still face substantial barriers to access, according to a new analytic essay by Mara Buchbinder, PhD, an associate professor in the department of social medicine.
“People think the main barrier is their state’s legal status and that legalization will resolve access issues. My research suggests otherwise,” Buchbinder said.
Her analysis was recently published online by the American Journal of Public Health.
Buchbinder’s article argues that although medical aid-in-dying laws are on the rise in the U.S., legalization does not guarantee access. Patients can and do encounter substantial barriers to access in jurisdictions where medical aid-in-dying is legal, and access is hindered by the same socioeconomic inequalities that are common in U.S. health care.
For example, patients with higher incomes have easier access to physicians who are willing to prescribe the lethal medication. They are also more likely to have insurance that will cover it, or to be able to afford to pay for these services themselves.
You can read the full article here.